Navigation Links
Romark and Intercell Join Forces in Combining Therapies Against Hepatitis C
Date:10/21/2010

TAMPA, Fla., Oct. 21 /PRNewswire/ -- Romark Laboratories, L.C. and Intercell AG (VSE; "ICLL") today announced plans to commence clinical trials of Romark's antiviral drug, nitazoxanide, in combination with Intercell's investigational therapeutic hepatitis C virus (HCV) vaccine, IC41, during the first half of 2011.

(Logo: http://photos.prnewswire.com/prnh/20100201/FL47022LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100201/FL47022LOGO)

Intercell's vaccine candidate has demonstrated a sustained reduction of viral load in chronic hepatitis C (CHC) patients in a phase II proof-of-concept trial. Nitazoxanide is an oral therapy that targets host cell factors involved in HCV replication and is not associated with viral mutations conferring resistance. Nitazoxanide has been shown to induce sustained virologic response as monotherapy in some patients chronically infected with HCV.

The planned European phase II trial will include approximately 60 treatment-naive patients chronically infected with HCV genotype-1 in three treatment arms: (1) IC41 plus nitazoxanide, (2) IC41 plus nitazoxanide and Pegasys® (peginterferon alfa-2a) and (3) Pegasys and Copegus® (ribavirin), the current standard of care, as an active control. The primary endpoint will be sustained virologic response (no detectable HCV RNA 24 weeks after end-of-treatment). The companies involved in the combination study will retain commercial rights for their respective products.

"We are excited about this novel therapeutic approach for chronic hepatitis C," said Jean-Francois Rossignol, M.D., Ph.D., Chairman and Chief Science Officer of Romark. "There is an important need for novel therapies that offer improvements in safety and efficacy compared to current standard therapy. Our development program for nitazoxanide in combination with peginterferon addresses this need and promises to change paradigms for therapy of chronic hepatitis C. The planned study of nitazo
'/>"/>

SOURCE Romark Laboratories, L.C.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Intercell and Romark Join Forces in Combining Therapies Against Hepatitis C
2. NeuroFocus and New Scientist Magazine Apply Neuromarketing to Select Cover Design
3. Romark Initiates Clinical Trial of Alinia for Treatment of Influenza
4. Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders
5. Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008
6. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
7. Romark Laboratories Raises $18 Million in Institutional Financing
8. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
9. Intercell AG Appoints Staph Leavenworth Bakali as Chief Business Officer
10. Intercell Acquires Antibody Technology Platform to Further Exploit Its Capabilities to Combat Infectious Diseases
11. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... TEANECK, N.J. , May 21, 2013 /PRNewswire-iReach/ ... 17-19 in NJ has attracted the greatest number ... reports its President, Mark Alexay ... "But suddenly everyone plans to attend this year.  The show,s still ... of different companies.  This is a big surprise ...
(Date:5/21/2013)... 21, 2013  Decision Resources, one of ... for pharmaceutical and healthcare issues, finds that ... key efficacy endpoints, including overall survival and ... influence over surveyed U.S. and European oncologists, ... HER2-negative breast cancer. The two novel emerging ...
(Date:5/21/2013)... 21, 2013  IsoRay, Inc. (AMEX: ISR ... entered into an exclusive international distribution agreement with IASIS ... in Greece . IsoRay is a ... medical radioisotope applications for brain cancer, lung cancer, head ... IASIS Medical is ideally suited to ...
Breaking Medicine Technology:Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3
... Palatin Technologies, Inc. (NYSE Amex: PTN ) announced that ... on Thursday, October 29, 2009 at 8:30 AM PDT. ... BIO Investor Forum will take place October 28-29 at the ... Spana, Ph.D., President and Chief Executive Officer of Palatin Technologies, ...
... Minimally Invasive Surgery Symposium (MISS) will include discussion of ... surgery, single-port bariatric surgery, transoral gastroplasty, and other "frontier" ... by MISS Executive Director Philip R Schauer, MD, on ... , The five-day CME conference, which will be held ...
Cached Medicine Technology:Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego 2
(Date:5/21/2013)... New York, New York (PRWEB) May 21, 2013 ... for Wright Conserve hip replacement lawsuits ... issued an Order in response to a request from ... employees of the Defendant. The May 17th Order ... such interviews may be conducted. (In re: Wright Medical ...
(Date:5/21/2013)... Angeles, CA (PRWEB) May 21, 2013 ... sports organization, and Bodybuilding.com, the largest online retailer of ... you a new reality-based sports show, Warrior Island. ... vote on; YouTube, Facebook & Twitter, with our unique ... Warrior Island maroons these elite fighters on an island ...
(Date:5/21/2013)... the roles two proteins, thrombospondin-1 and prosaposin, play ... has identified a five-amino acid fragment of prosaposin ... of prostate, breast and lung cancer. The findings ... metastasis in a variety of cancers. , ... at Boston Children,s Hospital, Vivek Mittal, PhD, at ...
(Date:5/21/2013)... Adenotonsillectomy, or the removal of the adenoids and ... United States, often as a treatment for children with ... improve a child,s attention and executive functioning, behavior, sleep ... rigorously evaluated until now. A study led by ... in Sleep and Cardiovascular Medicine and Associate Clinic Director ...
(Date:5/21/2013)... Harbor, Florida (PRWEB) May 21, 2013 ... agency, announced today that they have redesigned their website ... a nude beach, pool, hot tubs, bars and dining. ... this nudist resort including sales and guest reviews, will ... island of Jamaica itself, including pages on culinary local ...
Breaking Medicine News(10 mins):Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 3Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3Health News:Changing cancer's environment to halt its spread 2Health News:Changing cancer's environment to halt its spread 3Health News:Early removal of adenoids and tonsils can help pediatric sleep apnea symptoms 2Health News:The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography 2
... ... High Point Solutions has been awarded the prestigious Gold ... training, support and specialization. The Certification recognizes High Point,s expert ... Solutions, Wireless, Unified Communication, and Data Center. Gold Certified Partners are ...
... the first ever found to prevent cartilage loss from osteoarthritis ... cartilage that has been lost to osteoarthritis, according to an ... American Society for Bone and Mineral Research in Denver. While ... osteoarthritis that develops following knee injuries, according to the study ...
... waits for transplants , SATURDAY, Sept. 12 (HealthDay News) -- ... of donating some or all of their organs after death ... Just 38 percent of licensed drivers in the United States ... report this year by Donate Life America, a national alliance ...
... , , FRAMINGHAM, Mass., Sept. ... its more than 750,000 subscribers of its personal emergency response service ... help button. The service is used primarily by seniors living independently ... By pressing a "help button" worn on the body, users connect ...
... , WASHINGTON, Sept. 11 As the nation ... Advisory Board released a report today calling on policymakers to find ... , , The report, The Unsustainable Cost ... faster than the incomes of workers, retirees, and governments. If unaddressed, ...
... sound to young adults with acoustic neuromas , FRIDAY, Sept. ... longer hear her mother,s voice or the sound of a ... Garrett learned she had neurofibromatosis type 2 (NF2), a condition ... acoustic neuromas, damaged the eighth cranial nerve in one ear. ...
Cached Medicine News:Health News:High Point Solutions has Been Awarded the Prestigious Gold Certification from Cisco Systems 2Health News:Hormone promises to keep joint injuries from causing long-term osteoarthritis 2Health News:Hormone promises to keep joint injuries from causing long-term osteoarthritis 3Health News:Hormone promises to keep joint injuries from causing long-term osteoarthritis 4Health News:For Organ Donation, Intent and Reality Don't Align 2Health News:For Organ Donation, Intent and Reality Don't Align 3Health News:Lifeline Issues Safety Notice to Subscribers 2Health News:Social Security Advisory Board Warns of Consequences of Unsustainable Growth in The Cost of Health Care 2Health News:Cancer Drug Shrinks Benign Tumors That Steal Hearing 2Health News:Cancer Drug Shrinks Benign Tumors That Steal Hearing 3
Hand antisepsis plays a significant role in preventing nosocomial infections and the associated morbidity, mortality and costs. 3M offers healthcare providers effective hand antisepsis products that ...
BD Persist Plus protective barrier skin preps with chlorhexidine in alcohol...
IV Prep Antiseptic Wipes are effective and easy to apply. They are ideal for preparation of the skin prior to a ventipuncture or injection....
Triad Plus Sterile Isopropyl Alcohol 70% USP Prep Pads are medium size. Each package is terminally sterilized, ensuring the safest possible product....
Medicine Products: